Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
108 hedge funds and large institutions have $3.31B invested in Allergan plc in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 26 reducing their positions, and 16 closing their positions.
77% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 26
38% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 16
5% more funds holding
Funds holding: 103 → 108 (+5)
9% less capital invested
Capital invested by funds: $3.64B → $3.31B (-$337M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$167M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$108M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$88.8M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$46.1M |
| 5 |
LCM
Lakewood Capital Management
New York
|
+$44.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$174M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$124M |
| 3 |
O
OrbiMed
New York
|
-$87M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$80.7M |
| 5 |
SC
Sculptor Capital
New York
|
-$61.6M |
AGN.PRA Hedge Fund Activity: Q2 2016 in Review
108 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q2 2016, worth a combined $3.31B — down 9.2% from $3.64B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new AGN.PRA positions and 16 closed out — a net gain of 6 holders — while 46 added to existing stakes and 26 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $167M. The largest seller was Discovery Capital Management, exiting entirely with an estimated $174M sold.
- 108 institutional investors held Allergan plc (AGN.PRA) as of Q2 2016, up from 103 in Q1 2016.
- Funds reported $3.31B of Allergan plc stock for Q2 2016, down 9.2% quarter-over-quarter.
- 22 funds opened new Allergan plc positions in Q2 2016 and 16 closed out, a net change of +6 holders.
- The largest Allergan plc buyer in Q2 2016 was AQR Arbitrage, an estimated $167M added.
- The largest Allergan plc seller in Q2 2016 was Discovery Capital Management, an estimated $174M sold.
Based on aggregated 13F filings for Q2 2016.